NEW YORK (GenomeWeb News) — GeneGo today said it will work with the Cystic Fibrosis Foundation to develop a software suite to handle data from cystic fibrosis drug-development studies.  
 
The new platform, called MetaMiner, will include off-the-shelf GeneGo products such as MetaCore, MetaDrug, MetaLink, and MapEditor. MetaMiner will include -omics and small experiments specific to cystic fibrosis that have been annotated by GeneGo.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.